博文

Dr Nittaya Phanuphak: taking proactive and effective PrEP can reduce the risk of HIV infection

Dr Harry Janssen: how can we prevent hepatitis b/c reactivation in immunotherapy patients?

Dr. Bruno Sangro talks about the latest progress of immunotherapy for hepatocellular carcinoma

Dr. Lorenza Rimassa talked about the first-line and second-line selection of liver cancer under the new immune therapy, and the prospect of early and medium-term treatment

Prof. Fabien Zoulim:How to achieve functional cure of chronic hepatitis B?